Barclays Capital maintained the stock with “Equal Weight” rating in Tuesday, April 11 report. The stock of Fiserv Inc (NASDAQ:FISV) earned “Market Perform” rating by Cowen & Co on Wednesday, September 30. The stock has “Buy” rating by Roth Capital on Thursday, October 29. The company was downgraded on Thursday, August 4 by Mizuho. Envestnet Asset Management Inc. acquired a new position in shares of Sucampo Pharmaceuticals during the fourth quarter worth approximately $115,000. Therefore 67% are positive. See Sucampo Pharmaceuticals, Inc. The company’s 50 day moving average is $10.58 and its 200-day moving average is $10.73. Sucampo Pharma had 24 analyst reports since August 6, 2015 according to SRatingsIntel.
Sucampo Pharmaceuticals, Inc.is a biopharmaceutical company. On Tuesday, February 9 the stock rating was initiated by UBS with “Buy”. Mizuho upgraded Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for 59,044 shares. (NASDAQ:SCMP) earned “Neutral” rating by Mizuho on Friday, October 9. ValuEngine lowered shares of Sucampo Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. On Thursday, August 6 the stock rating was maintained by WallachBeth Capital with “Hold”. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, June 20. Ladenburg Thalmann upgraded the shares of CNMD in report on Monday, October 12 to “Buy” rating.
08/27/2015 – Sucampo Pharmaceuticals, Inc. had its ” rating reiterated by analysts at H.C. Wainwright. The rating was maintained by Piper Jaffray on Thursday, August 27 with “Neutral”. The stock rose 1.00% or $0.1 reaching $10.6 per share. The original version of this report can be viewed at https://transcriptdaily.com/2017/08/02/sucampo-pharmaceuticals-inc-scmp-releases-earnings-results-beats-estimates-by-0-01-eps.html. It has underperformed by 22.00% the S&P500.;
Investors sentiment increased to 1.98 in Q4 2016. At present, 0 analysts call it Sell, while 1 think it is Hold. Sucampo Pharmaceuticals updated its FY17 guidance to $1.00-1.10 EPS. 46 funds opened positions while 49 raised stakes. (NASDAQ:SCMP) or 54,700 shares. It also increased its holding in Vanguard Bd Index Fd Inc (BSV) by 203,029 shares in the quarter, for a total of 529,146 shares, and has risen its stake in Vanguard Tax Managed Intl Fd (VEA). Legal & General Group Plc stated it has 6,555 shares or 0% of all its holdings. The stock tapped a 52-week high of US$36.83 while the mean 12-month price target for the shares is US$38.67. Vanguard Gp Inc owns 978,561 shares. (NASDAQ:SCMP) for 34,044 shares. 160,559 were accumulated by D E Shaw And. Prudential Finance holds 0.01% of its portfolio in Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). Ativo Capital Mgmt Limited has invested 0.35% in Sucampo Pharmaceuticals, Inc. Hedge funds and other institutional investors own 55.82% of the company’s stock. (NASDAQ:SCMP). Blackrock Group Inc Ltd owns 0% invested in Sucampo Pharmaceuticals, Inc. About 3,600 shares traded. First Tru Advsr L P stated it has 27,824 shares or 0% of all its holdings. 64,248 are held by Brandywine Investment Management Limited Liability. Koffler covers the Healthcare sector, focusing on stocks such as Synergy Pharmaceuticals Inc, Apricus Biosciences Inc, and Pacira Pharmaceuticals. The stock has a market capitalization of $480.90 million, a PE ratio of 17.25 and a beta of 1.48.
10/29/2015 – Roth Capital began new coverage on Sucampo Pharmaceuticals, Inc. giving the company a ” rating. The return on equity ratio or ROE stands at 17.8 percent while most common profitability ratio return on investment (ROI) was 9.6 percent. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Computacenter plc (LON:CCC) has 0.00% since August 2, 2016 and is.
Computacenter plc is a provider of information technology infrastructure services. The company’s market cap is $481.81 million. The Company’s divisions include UK, Germany, France and Belgium. The Firm advises organizations on IT strategy, implement technology and manages its customers’ infrastructures.
Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.23, from 1.39 in 2016Q3. The fund owned 84,241 shares of the biopharmaceutical company’s stock after selling 28 shares during the period. Mason Street Ltd stated it has 11,064 shares or 0.01% of all its holdings. New York-based Grandfield Dodd Ltd Liability Company has invested 0.06% in Fiserv Inc (NASDAQ:FISV). Moreover, Johnson Finance Grp Inc has 0% invested in Computacenter plc (LON:CCC) for 1,175 shares. Retirement Systems Of Alabama owns 105,888 shares for 0.07% of their portfolio. North Point Port Managers Oh owns 140,362 shares. Louisiana State Employees Retirement System acquired a new position in Sucampo Pharmaceuticals during the first quarter valued at approximately $111,000.
Sabby Mngmt Limited Co holds 75,000 shares or 0.06% of its portfolio. Hsbc Public Limited Company reported 0% in Computacenter plc (LON:CCC).